Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05943145
Other study ID # 23-100
Secondary ID 1863441-38-20
Status Completed
Phase N/A
First received
Last updated
Start date April 24, 2023
Est. completion date November 27, 2023

Study information

Verified date November 2023
Source GroundWorks DanceTheater
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

GroundWorks DanceTheater and Cleveland Clinic are partnering to create and offer an initial study of a dance movement-based community program for people with Multiple Sclerosis (MS). The program will address major needs in the MS community including social-emotional well-being, body awareness, and motor function. GroundWorks artists will use a variety of widely accepted movement-based practices with the goal of improving upper and lower body function and overall well-being. By partnering, GroundWorks and Cleveland Clinic hope to encourage more study of the benefits of dance movement-based programming in individuals affected by MS.


Description:

GroundWorks DanceTheater and Cleveland Clinic are partnering to design and implement a pilot study of a dance movement-based community program for people with Multiple Sclerosis (MS). The program is aimed at addressing major needs in the MS community including social-emotional well-being, body awareness, and motor function. GroundWorks artists will use a variety of movement-based practices including personalized tasks and imagery, mirroring, and inscription, with the goal of improving upper and lower extremity function, and well-being. Cleveland Clinic will assist GroundWorks in the selection, monitoring, and testing of the participants. Cleveland Clinic will also take the lead with data management and analysis. By partnering, GroundWorks and Cleveland Clinic hope to create a promising program that will lead to further exploring the impact of dance movement-based programming in individuals affected by MS.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date November 27, 2023
Est. primary completion date July 14, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - age 18 to 65 inclusive - diagnosis of MS (relapsing or progressive form) based on the revised MacDonald Criteria established by a neurologist - self-reported upper and lower extremity dysfunction - ability to walk safely without an assistive device (e.g. cane, walker) indoors and outdoors Exclusion Criteria: - comorbidity (e.g. cardiac, respiratory, musculoskeletal) representing a contra-indication to the dance movement program - exacerbation of MS within the past 60 days - severe cognitive impairment - clinically significant concern regarding the participant's ability to safely perform study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Group Dance and Movement Training
Dance movement-based sessions including personalized tasks and imagery, mirroring, and inscription, plus warm-up and cool down practices to ensure physical safety

Locations

Country Name City State
United States Cleveland State University Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
GroundWorks DanceTheater

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Timed Up and Go (TUG) This is a test of functional mobility, commonly used for people with MS. The test measures the time it takes for a person to stand up from a chair, walk 10 feet, turn around, walk back to the chair and sit down. 4 months
Primary 9 Hole Peg Test (NHPT) This is a widely used test of upper extremity function in people with MS. The test measures the time it takes for a person to pick up 9 pegs individually and place each one in one of 9 holes on a board and then take each one out, one at a time, and place the pegs back in the container. 4 months
Secondary Neuro-QOL Positive Affect and Well-Being - Short Form This is a self-reported quality of life measure which has been validated in people with MS to assess positive affect and well-being. 4 months
Secondary Neuro-QOL Lower Extremity Function (Mobility) - Short Form This is a self-reported quality of life measure which has been validated in people with MS to assess mobility. 4 months
Secondary Neuro-QOL Upper Extremity Function (Fine Motor, ADL) - Short Form This is a self-reported quality of life measure which has been validated in people with MS to assess fine motor and ADLs. 4 months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4